Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""PSORIASIS"" wg kryterium: Temat


Tytuł :
Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy.
Autorzy :
Khater MH; Assistant Professor of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
AbdallaAlhabib S; M.B.B.Ch, Benghazi University, Benghazi, Libya.
Elkshishy KA; Professor of Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Khattab FM; Assistant Professor of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Pokaż więcej
Źródło :
The Journal of dermatological treatment [J Dermatolog Treat] 2020 Dec; Vol. 31 (8), pp. 758-762. Date of Electronic Publication: 2019 Oct 10.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Galectin 3/*blood
Psoriasis/*blood
Ultraviolet Therapy/*methods
Adult ; Biomarkers/analysis ; Biomarkers/blood ; Case-Control Studies ; Cross-Sectional Studies ; Female ; Galectin 3/analysis ; Galectin 3/antagonists & inhibitors ; Humans ; Keratinocytes ; Male ; Middle Aged ; Psoriasis/pathology ; Psoriasis/radiotherapy ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
Autorzy :
Gelfand JM; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Informatics and the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: .
Armstrong AW; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Bell S; National Psoriasis Foundation, Portland, Oregon.
Anesi GL; Department of Biostatistics, Epidemiology and Informatics and the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Pulmonary, Allergy, and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Blauvelt A; Oregon Medical Research Center, Portland, Oregon.
Calabrese C; Department of Rheumatology and Immunology, Cleveland Clinic, Cleveland, Ohio.
Dommasch ED; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
Feldman SR; Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Gladman D; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Kircik L; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Dermatology, Indiana University Medical Center, Indianapolis, Indiana.
Lebwohl M; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
Lo Re V 3rd; Department of Biostatistics, Epidemiology and Informatics and the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Martin G; Dermatology Associates, Maui, Hawaii.
Merola JF; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Scher JU; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine and New York University Langone Orthopedic Hospital, New York, New York.
Schwartzman S; Department of Rheumatology, Hospital for Special Surgery, New York, New York.
Treat JR; Department of Pediatric Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Van Voorhees AS; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia.
Ellebrecht CT; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Fenner J; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
Ocon A; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York.
Syed MN; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Weinstein EJ; Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Smith J; National Psoriasis Foundation, Portland, Oregon.
Gondo G; National Psoriasis Foundation, Portland, Oregon.
Heydon S; National Psoriasis Foundation, Portland, Oregon.
Koons S; National Psoriasis Foundation, Portland, Oregon.
Ritchlin CT; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York.
Pokaż więcej
Źródło :
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Dec; Vol. 83 (6), pp. 1704-1716. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Practice Guideline
MeSH Terms :
Coronavirus Infections/*epidemiology
Immunosuppressive Agents/*adverse effects
Organizations, Nonprofit/*standards
Pneumonia, Viral/*epidemiology
Psoriasis/*drug therapy
Advisory Committees/standards ; Betacoronavirus/immunology ; Betacoronavirus/pathogenicity ; COVID-19 ; Consensus ; Coronavirus Infections/immunology ; Coronavirus Infections/prevention & control ; Coronavirus Infections/virology ; Critical Care/standards ; Delphi Technique ; Dermatology/standards ; Epidemiology/standards ; Humans ; Infectious Disease Medicine/standards ; Organizations, Nonprofit/organization & administration ; Pandemics/prevention & control ; Pneumonia, Viral/immunology ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/virology ; Psoriasis/complications ; Psoriasis/immunology ; Rheumatology/standards ; SARS-CoV-2 ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Does therapy with biological drugs influence COVID-19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone.
Autorzy :
Brazzelli V; Institute of Dermatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Isoletta E; Institute of Dermatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Barak O; Institute of Dermatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Barruscotti S; Institute of Dermatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Vassallo C; Institute of Dermatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Giorgini C; Institute of Dermatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Michelerio A; Institute of Dermatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Tomasini CF; Institute of Dermatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
Musella V; Unit of Clinical Epidemiology and Biometrics, Scientific Direction, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Klersy C; Unit of Clinical Epidemiology and Biometrics, Scientific Direction, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14516. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Biological Products/*administration & dosage
COVID-19/*epidemiology
Dermatologic Agents/*administration & dosage
Immunosuppressive Agents/*administration & dosage
Psoriasis/*drug therapy
Adult ; Aged ; Biological Products/adverse effects ; COVID-19/immunology ; Dermatologic Agents/adverse effects ; Drug Administration Schedule ; Female ; Humans ; Immunocompromised Host ; Immunosuppressive Agents/adverse effects ; Italy/epidemiology ; Male ; Middle Aged ; Prevalence ; Prospective Studies ; Psoriasis/epidemiology ; Psoriasis/immunology ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
COVID-19 and psoriasis: Recommendation for patients on regular infliximab therapy.
Autorzy :
Li S; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Zhang S; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Wu R; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Su Y; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14472. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19*
Health Services Accessibility*
Telemedicine*
Dermatologic Agents/*therapeutic use
Infliximab/*therapeutic use
Psoriasis/*drug therapy
Adult ; Dermatologic Agents/supply & distribution ; Drug Substitution ; Female ; Humans ; Male ; Middle Aged ; Psoriasis/diagnosis ; Psoriasis/immunology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study.
Autorzy :
Akdogan N; Department of Dermatology and Venereology, School of Medicine, Hacettepe University, Ankara, Turkey.
Dogan S; Department of Dermatology and Venereology, School of Medicine, Hacettepe University, Ankara, Turkey.
Atakan N; Department of Dermatology and Venereology, School of Medicine, Hacettepe University, Ankara, Turkey.
Pokaż więcej
Źródło :
The Journal of dermatological treatment [J Dermatolog Treat] 2020 Nov; Vol. 31 (7), pp. 702-706. Date of Electronic Publication: 2019 May 01.
Typ publikacji :
Journal Article
MeSH Terms :
Biological Therapy*
Eosinophils/*drug effects
Psoriasis/*immunology
Adalimumab/pharmacology ; Adalimumab/therapeutic use ; Adult ; Etanercept/pharmacology ; Etanercept/therapeutic use ; Female ; Humans ; Infliximab/pharmacology ; Infliximab/therapeutic use ; Longitudinal Studies ; Male ; Middle Aged ; Psoriasis/blood ; Psoriasis/drug therapy ; Retrospective Studies ; Ustekinumab/pharmacology ; Ustekinumab/therapeutic use
Czasopismo naukowe
Tytuł :
Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis.
Autorzy :
Pinter A; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Gerdes S; Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany.
Papavassilis C; Novartis Pharma AG, Basel, Switzerland.
Reinhardt M; Novartis Pharma GmbH, Nürnberg, Germany.
Pokaż więcej
Źródło :
The Journal of dermatological treatment [J Dermatolog Treat] 2020 Dec; Vol. 31 (8), pp. 769-775. Date of Electronic Publication: 2019 Jul 16.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Interleukin-17/*antagonists & inhibitors
Psoriasis/*drug therapy
Adult ; Body Weight ; Etanercept/therapeutic use ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Psoriasis/immunology ; Smoking ; Treatment Outcome ; Ustekinumab/therapeutic use
Czasopismo naukowe
Tytuł :
Hypertension in psoriasis patients: based on office and ambulatory blood pressure measurement.
Autorzy :
Abedini R; Department of Dermatology, Razi Hospital.
Najafi MT; Nephrology Research Center.
Azizpour A; Department of Dermatology, Razi Hospital.
Nasimi M; Department of Dermatology, Razi Hospital.
Darreshiri M; Tehran University of Medical Sciences.
Teymourpour A; Student of biostatistics, school of Public health, Tehran University of Medical sciences, Tehran, Iran.
Pokaż więcej
Źródło :
Blood pressure monitoring [Blood Press Monit] 2020 Dec; Vol. 25 (6), pp. 351-354.
Typ publikacji :
Journal Article
MeSH Terms :
Hypertension*/complications
Hypertension*/diagnosis
Hypertension*/epidemiology
Psoriasis*/complications
Psoriasis*/diagnosis
Psoriasis*/epidemiology
Blood Pressure ; Blood Pressure Determination ; Blood Pressure Monitoring, Ambulatory ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Chemical profiling and anti-psoriatic activity of marine sponge (Dysidea avara) in induced imiquimod-psoriasis-skin model.
Autorzy :
Khaledi M; Marine Pharmaceutical Science Research Center, Department of Pharmacognosy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Sharif Makhmal Zadeh B; Nanotechnology Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Rezaie A; Department of Pathobiology Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Nazemi M; Gulf and Oman Sea Ecological Research Center, Iranian Fisheries Science Research Institute (IFSRI), Agricultural Research, Education and Extension Organization (AREEO), Bandar Abbas, Iran.
Safdarian M; Nanotechnology Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Nabavi MB; Halal Research Center of Islamic Republic of Iran, Tehran, Iran.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 30; Vol. 15 (11), pp. e0241582. Date of Electronic Publication: 2020 Nov 30 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Dysidea*
Anti-Inflammatory Agents/*pharmacology
Biological Products/*pharmacology
Psoriasis/*drug therapy
Skin/*drug effects
Animals ; Anti-Inflammatory Agents/therapeutic use ; Biological Products/therapeutic use ; Disease Models, Animal ; Drug Evaluation, Preclinical ; Female ; Humans ; Imiquimod/toxicity ; Interleukin-17/analysis ; Interleukin-17/metabolism ; Interleukins/analysis ; Interleukins/metabolism ; Mice ; Psoriasis/chemically induced ; Psoriasis/diagnosis ; Psoriasis/immunology ; Severity of Illness Index ; Skin/immunology ; Skin/metabolism ; Skin/pathology ; Tumor Necrosis Factor-alpha/analysis ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
Thymol activates TRPM8-mediated Ca influx for its antipruritic effects and alleviates inflammatory response in Imiquimod-induced mice.
Autorzy :
Wang W; School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China.
Wang H; College of Life Sciences, South-Central University for Nationalities, Wuhan 430074, China.
Zhao Z; Washington University School of Medicine, St. Louis, MO 63110, United States; Barnes-Jewish Hospital, St. Louis, MO 63110, United States.
Huang X; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education), School of Pharmaceutical Sciences, Wuhan University, Wuhan 430072, China.
Xiong H; College of Life Sciences, South-Central University for Nationalities, Wuhan 430074, China. Electronic address: .
Mei Z; School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China. Electronic address: .
Pokaż więcej
Źródło :
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2020 Nov 15; Vol. 407, pp. 115247. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Imiquimod*
Antipruritics/*pharmacology
Calcium/*metabolism
Psoriasis/*drug therapy
TRPM Cation Channels/*agonists
Thymol/*pharmacology
Animals ; Behavior, Animal ; Cell Differentiation/drug effects ; Cytokines/blood ; Cytokines/metabolism ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Neurons/drug effects ; Pruritus/chemically induced ; Pruritus/prevention & control ; Pruritus/psychology ; Psoriasis/chemically induced ; Skin/drug effects ; Skin/metabolism
Czasopismo naukowe
Tytuł :
Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis.
Autorzy :
Liu ZJ; Department of Dermatology.
Tian YT; Neurology Department, the First Affiliated Hospital of Shihezi University School of medicine, Shihezi city, Xinjiang, China.
Shi BY; Department of Dermatology.
Zhou Y; Department of Dermatology.
Jia XS; Department of Dermatology.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Nov 06; Vol. 99 (45), pp. e23068.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Genetic Predisposition to Disease/*genetics
Interleukins/*genetics
Polymorphism, Single Nucleotide/*genetics
Psoriasis/*genetics
Adolescent ; Asian Continental Ancestry Group/genetics ; China/epidemiology ; Data Management ; European Continental Ancestry Group/genetics ; Genetic Predisposition to Disease/ethnology ; Heterozygote ; Homozygote ; Humans ; Mutation/genetics ; Psoriasis/microbiology ; Psoriasis/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Comment on "Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment".
Autorzy :
Farabi B; Department of Dermatology, Robert Wood Johnson Medical Center, Rutgers University, New Brunswick, New Jersey, USA.; Department of Dermatology, Ankara University School of Medicine, Ankara, Turkey.
Bhargava S; Department of Dermatology, R. D. Gardi Medical College, Ujjain, India.
Goldust M; Department of Dermatology, University Hospital Basel, Basel, Switzerland.
Atak MF; Department of Dermatology, Ankara University School of Medicine, Ankara, Turkey.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e13840. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji :
Letter; Comment
MeSH Terms :
COVID-19*
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Respiratory Distress Syndrome*/diagnosis
Respiratory Distress Syndrome*/therapy
Humans ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Efficacy and safety of pioglitazone for treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.
Autorzy :
Chang G; Dermatology and Venereology, Graduate School of Tianjin Medical University, Tianjin, China.
Wang J; Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine of Affiliated Hospital, Tianjin, China.
Song J; Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine of Affiliated Hospital, Tianjin, China.
Zhang Z; Department of Dermatology, Binhai Hospital of Tianjin Medical University General Hospital, Tianjin, China.
Zhang L; Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine of Affiliated Hospital, Tianjin, China.
Pokaż więcej
Źródło :
The Journal of dermatological treatment [J Dermatolog Treat] 2020 Nov; Vol. 31 (7), pp. 680-686. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Journal Article
MeSH Terms :
Dermatologic Agents/*therapeutic use
Pioglitazone/*therapeutic use
Psoriasis/*drug therapy
Combined Modality Therapy ; Dermatologic Agents/adverse effects ; Drug Therapy, Combination ; Humans ; Phototherapy ; Pioglitazone/adverse effects ; Psoriasis/therapy ; Randomized Controlled Trials as Topic ; United Kingdom
Czasopismo naukowe
Tytuł :
Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17?
Autorzy :
Carugno A; Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Gambini DM; Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Raponi F; Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Vezzoli P; Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Robustelli Test E; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Arosio MEG; Microbiology and Virology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.; Biobank Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Callegaro A; Microbiology and Virology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.; Biobank Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Sena P; Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14011. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Antibodies, Monoclonal, Humanized/*administration & dosage
COVID-19/*virology
Dermatologic Agents/*administration & dosage
Exanthema/*immunology
Psoriasis/*drug therapy
SARS Virus/*pathogenicity
Aged ; Antibodies, Monoclonal, Humanized/adverse effects ; COVID-19/diagnosis ; COVID-19/immunology ; Dermatologic Agents/adverse effects ; Drug Administration Schedule ; Exanthema/diagnosis ; Exanthema/virology ; Host-Pathogen Interactions ; Humans ; Male ; Psoriasis/diagnosis ; Psoriasis/immunology ; SARS Virus/immunology
Raport
Tytuł :
Cellular scars and local crosstalk in relapsing psoriasis: an example of a skin sticking disease.
Autorzy :
Gallais Sérézal I; Department of Medicine, Unit of Rheumatology Karolinska Institutet Solna, Stockholm, Sweden.; Department of Dermatology, Besançon University Hospital, Besançon, France.
Cheuk S; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden.; Department of Paediatrics, University of Oxford, Oxford, UK.
Martini E; Department of Medicine, Unit of Rheumatology Karolinska Institutet Solna, Stockholm, Sweden.
Eidsmo L; Department of Medicine, Unit of Rheumatology Karolinska Institutet Solna, Stockholm, Sweden.; Diagnostiskt Centrum Hud, Stockholm, Sweden.
Pokaż więcej
Źródło :
Scandinavian journal of immunology [Scand J Immunol] 2020 Nov; Vol. 92 (5), pp. e12953. Date of Electronic Publication: 2020 Sep 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cicatrix/*immunology
Cytokines/*immunology
Interleukin-17/*immunology
Keratinocytes/*immunology
Psoriasis/*immunology
Skin/*immunology
Cicatrix/metabolism ; Cytokines/metabolism ; Epidermis/immunology ; Epidermis/metabolism ; Epidermis/pathology ; Humans ; Immunologic Memory/immunology ; Interleukin-17/metabolism ; Keratinocytes/metabolism ; Keratinocytes/pathology ; Psoriasis/metabolism ; Recurrence ; Skin/metabolism ; Skin/pathology
Czasopismo naukowe
Tytuł :
Blood microRNA expressions in patients with mild to moderate psoriasis and the relationship between microRNAs and psoriasis activity.
Autorzy :
Alatas ET; Department of Dermatology, School of Medicine, University of Mugla, Turkey. Electronic address: .
Kara M; Department of Medical Genetics, School of Medicine, University of Mugla, Turkey.
Dogan G; Department of Dermatology, School of Medicine, University of Mugla, Turkey.
Akın Belli A; Erdem Hospital, İstanbul, Turkey.
Pokaż więcej
Źródło :
Anais brasileiros de dermatologia [An Bras Dermatol] 2020 Nov - Dec; Vol. 95 (6), pp. 702-707. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji :
Journal Article
MeSH Terms :
MicroRNAs*/genetics
Psoriasis*/genetics
Biomarkers ; Case-Control Studies ; Humans ; Real-Time Polymerase Chain Reaction
Czasopismo naukowe
Tytuł :
Psoriasis-associated angiogenesis is mediated by EDIL3.
Autorzy :
Niu X; Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Han Q; Department of Dermatology, the First Hospital of China Medical University, Shenyang, Liaoning, China.
Liu Y; Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Li J; Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Hou R; Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Li J; Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Zhang K; Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China. Electronic address: .
Pokaż więcej
Źródło :
Microvascular research [Microvasc Res] 2020 Nov; Vol. 132, pp. 104056. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neovascularization, Pathologic*
Calcium-Binding Proteins/*metabolism
Cell Adhesion Molecules/*metabolism
Human Umbilical Vein Endothelial Cells/*metabolism
Mesenchymal Stem Cells/*metabolism
Psoriasis/*metabolism
Skin/*blood supply
Animals ; Calcium-Binding Proteins/genetics ; Case-Control Studies ; Cell Adhesion ; Cell Adhesion Molecules/genetics ; Cell Movement ; Cell Proliferation ; Cells, Cultured ; Coculture Techniques ; Disease Models, Animal ; Human Umbilical Vein Endothelial Cells/pathology ; Humans ; Mesenchymal Stem Cells/pathology ; Mice, Inbred BALB C ; Paracrine Communication ; Psoriasis/pathology ; Signal Transduction
Czasopismo naukowe
Tytuł :
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
Autorzy :
Ladda M; Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Lynde C; Lynde Institute for Dermatology, Markham, ON, Canada.; 210484 Division of Dermatology, Department of Medicine, University of Toronto, Toronto ON, Canada.
Fleming P; Lynde Institute for Dermatology, Markham, ON, Canada.; 210484 Division of Dermatology, Department of Medicine, University of Toronto, Toronto ON, Canada.
Pokaż więcej
Źródło :
Journal of cutaneous medicine and surgery [J Cutan Med Surg] 2020 Nov/Dec; Vol. 24 (6), pp. 625-632. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Pandemics*
SARS-CoV-2*
Biological Products/*therapeutic use
COVID-19/*epidemiology
Psoriasis/*drug therapy
Humans ; Psoriasis/epidemiology
Czasopismo naukowe
Tytuł :
Coronavirus disease 2019 in a psoriatic patient with concomitant chronic obstructive pulmonary disease under treatment with risankizumab.
Autorzy :
Kiss N; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Lőrincz K; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Medvecz M; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Fésűs L; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Csuha P; 3rd Department of Internal Medicine, Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
Hermányi Z; 3rd Department of Internal Medicine, Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
Wikonkál NM; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14186. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/immunology
Antibodies, Monoclonal/*therapeutic use
Biological Products/*therapeutic use
COVID-19/*virology
Dermatologic Agents/*therapeutic use
Psoriasis/*drug therapy
SARS-CoV-2/*pathogenicity
Aged ; Antibodies, Monoclonal/adverse effects ; Antiviral Agents/therapeutic use ; Biological Products/adverse effects ; COVID-19/diagnosis ; COVID-19/drug therapy ; COVID-19/immunology ; Dermatologic Agents/adverse effects ; Host-Pathogen Interactions ; Humans ; Male ; Psoriasis/diagnosis ; Psoriasis/immunology ; SARS-CoV-2/drug effects ; SARS-CoV-2/immunology ; Treatment Outcome
SCR Protocol :
COVID-19 drug treatment
Raport
Tytuł :
[PUSTULAR PSORIASIS DURING PREGNANCY: WHEN IS THE RIGHT TIME TO DELIVER?]
Autorzy :
Grinstein E; Department of Obstetrics and Gynecology, the Edith Wolfson Medical Center, Holon, Israel.
Landau M; Department of Dermatology, the Edith Wolfson Medical Center, Holon, Israel.
Vaknin H; Department of Pathology, the Edith Wolfson Medical Center, Holon, Israel.
Bar J; Department of Obstetrics and Gynecology, the Edith Wolfson Medical Center, Holon, Israel.
Kovo M; Department of Obstetrics and Gynecology, the Edith Wolfson Medical Center, Holon, Israel.
Pokaż więcej
Źródło :
Harefuah [Harefuah] 2020 Nov; Vol. 159 (11), pp. 789-792.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Dermatitis Herpetiformis*
Impetigo*
Pregnancy Complications*/diagnosis
Pregnancy Complications, Infectious*
Psoriasis*/complications
Psoriasis*/diagnosis
Female ; Humans ; Pregnancy ; Pregnancy Trimester, Third
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies